Domov › Rak jajčnikov › Virginia › Arlington
Klinične študije za Rak jajčnikov v Arlington, VA
46 študij za Rak jajčnikov išče udeležence na lokacijah v Arlington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Inova Fair Oaks Hospital, Fairfax · 11 mi stran
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- Inova Fairfax Hospital, Falls Church · 4 mi stran
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- Research Site, Fairfax · 11 mi stran
A Study of PHST001 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia, Fairfax · 11 mi stran
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- NEXT Virginia, Fairfax · 11 mi stran
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Vključevanje udeležencevFaza 2
- Next Virginia /ID# 279684, Fairfax · 11 mi stran
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Site 04, Fairfax · 11 mi stran
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Vključevanje udeležencevFaza 1
- Next Virginia /ID# 278607, Fairfax · 11 mi stran
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Vključevanje udeležencevFaza 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mi stran
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Vključevanje udeležencevFaza 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mi stran
Study of AVZO-021 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi stran
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mi stran
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, Fairfax · 11 mi stran
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Vključevanje udeležencevFaza 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Next Oncology Virginia, Fairfax · 11 mi stran
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mi stran
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Inova Schar Cancer Institute, Falls Church · 4 mi stran
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Vključevanje udeležencevFaza 1
- Normunity Investigational Site, Fairfax · 11 mi stran
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Vključevanje udeležencev
- Inova Fairfax Hospital, Falls Church · 4 mi stran
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Inova Fair Oaks Hospital, Fairfax · 11 mi stran
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Clinical Trial Site, Fairfax · 11 mi stran
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi stran
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Vključevanje udeležencevFaza 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Vključevanje udeležencevFaza 2
- 522, Fairfax · 11 mi stran
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi stran
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT, Fairfax · 11 mi stran
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Vključevanje udeležencevFaza 1
- Dren Investigational Site, Fairfax · 11 mi stran
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi stran
Študije za Rak jajčnikov v drugih mestih
- Houston, TX89 študij
- New York City, NY69 študij
- Boston, MA61 študij
- Los Angeles, CA50 študij
- Nashville, TN49 študij
- Philadelphia, PA44 študij
- Columbus, OH39 študij
- St. Louis, MO38 študij
- Chicago, IL36 študij
- San Antonio, TX31 študij
- Cleveland, OH30 študij
- Pittsburgh, PA30 študij
Druge študije v Arlington
- Nemalicelični pljučni rak104 študij
- Metastatski rak53 študij
- Kolorektalni rak52 študij
- Rak (vse vrste)48 študij
- Rak dojke47 študij
- Rak pljuč41 študij
- Rak endometrija39 študij
- Rak trebušne slinavke33 študij
- Ploščatocelični karcinom glave in vratu26 študij
- Mikrocitni rak pljuč23 študij
- Rak želodca20 študij
- Trojno negativni rak dojke20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.